Shaw, Gary
Cavalcante, Ludimila
Giles, Francis J.
Taylor, Alison
Funding for this research was provided by:
Actuate Therapeutics
Article History
Received: 6 May 2022
Accepted: 25 August 2022
First Online: 14 September 2022
Declarations
:
: The first-in-human study of 9-ING-41 (NCT03678883, EudraCT# 2018-003739-32), conducted in accordance with the International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS) and the Declaration of Helsinki, was approved by the institutional review board or independent ethics committee at each site. All participating patients provided written informed consent. The pre-clinical research was regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 Home Office UK PPL No. P0CFA732A and approved by the institutional animal use and care committee of the University of Leeds.
: Not applicable.
: AT received research grant to institution from Actuate Therapeutics to support pre-clinical studies. FG and LC were consultants to Actuate Therapeutics.